ADVOCATE. CONNECT. INNOVATE.

Category Archives: Policy Papers

2018 Talent Integration: California Workforce Trends in the Life Science Industry

The 2018 Talent Integration: California Workforce Trends in the Life Science Industry report captures up-to-date information on the most critical current and projected talent needs of California’s innovative life science industry. Produced by the California Life Sciences Institute and the Biocom Institute, the report shows that California’s life science industry continues to be one of California’s leading employers, creating jobs for over 360,000 people.

CLSA Report: Understanding Inflammatory Bowel Disease (IBD)

More than 3 million Americans suffer from Inflammatory Bowel Disease (IBD), an umbrella term for two distinct conditions – Crohn’s disease and ulcerative colitis. Download CLSA’s latest report to learn more about this disease, view patient stories, and learn how public policies can improve patient access to IBD therapies.

2018 California Life Sciences Industry Report

California Life Sciences Association (CLSA) and PwC US are proud to release the 2018 California Life Sciences Industry Report, which provides a snapshot of the largest life sciences cluster in the world and source of the greatest number of products in clinical development. The 2018 report shows that California continues to outpace other states in life science-related economic growth, and is producing nearly 300,000 jobs and shepherding more than a thousand new therapies through the pipeline.

2017 California Life Sciences Industry Report

California Life Sciences Association (CLSA) and PwC US issue new report indicating that California’s life sciences industry has 1,269 new medicines in the development pipeline, and in 2015, employed more than 287,000 people, brought in $148 billion in total revenue, paid over $116,000 in average wages, attracted $4.4 billion in venture capital investment and more.

2016 CA Workforce Trends in the Life Science Industry Report

California Life Sciences Association (CLSA) and PwC US issue new report indicating that California’s life sciences industry has 1,269 new medicines in the development pipeline, and in 2015, employed more than 287,000 people, brought in $148 billion in total revenue, paid over $116,000 in average wages, attracted $4.4 billion in venture capital investment and more.